These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. H3F3A G34 mutation DNA sequencing and G34W immunohistochemistry analysis in 366 cases of giant cell tumors of bone and other bone tumors. Gong L, Bui MM, Zhang W, Sun X, Zhang M, Yi D. Histol Histopathol; 2021 Jan; 36(1):61-68. PubMed ID: 33021329 [Abstract] [Full Text] [Related]
5. Mutation Analysis of H3F3A and H3F3B as a Diagnostic Tool for Giant Cell Tumor of Bone and Chondroblastoma. Cleven AH, Höcker S, Briaire-de Bruijn I, Szuhai K, Cleton-Jansen AM, Bovée JV. Am J Surg Pathol; 2015 Nov; 39(11):1576-83. PubMed ID: 26457357 [Abstract] [Full Text] [Related]
6. P63 expression as a biomarker discriminating giant cell tumor of bone from other giant cell-rich bone lesions. Shooshtarizadeh T, Rahimi M, Movahedinia S. Pathol Res Pract; 2016 Oct; 212(10):876-879. PubMed ID: 27473669 [Abstract] [Full Text] [Related]
8. H3F3A-mutated giant cell tumour of bone without giant cells-clinical presentation, radiology and histology of three cases. Leinauer B, Wolf E, Werner M, Baumhoer D, Breining T, Luebke AM, Maas R, Schultheiß M, von Baer A, Sufi-Siavach A, Moritz C, Geißler S, Mellert K, Möller P, Barth TFE, Jundt G. Histopathology; 2021 Nov; 79(5):720-730. PubMed ID: 33991114 [Abstract] [Full Text] [Related]
10. Absence of H3F3A mutation in a subset of malignant giant cell tumor of bone. Yoshida KI, Nakano Y, Honda-Kitahara M, Wakai S, Motoi T, Ogura K, Sano N, Shibata T, Okuma T, Iwata S, Kawai A, Ichimura K, Yoshida A. Mod Pathol; 2019 Dec; 32(12):1751-1761. PubMed ID: 31285528 [Abstract] [Full Text] [Related]
12. Giant cell tumours of bone treated with denosumab: histological, immunohistochemical and H3F3A mutation analyses. Kato I, Furuya M, Matsuo K, Kawabata Y, Tanaka R, Ohashi K. Histopathology; 2018 May; 72(6):914-922. PubMed ID: 29206281 [Abstract] [Full Text] [Related]
13. [New aspects on giant cell tumor of bone]. Lüke J, Hasenfratz M, Möller P, Barth TFE. Pathologe; 2018 Mar; 39(2):125-131. PubMed ID: 29110035 [Abstract] [Full Text] [Related]
14. Immunohistochemical expression of H3.3 G34W in 100 giant cell tumors of bone and its diagnostic mimics, including its value in resolving uncommon diagnostic scenarios: A single institutional study at a tertiary cancer referral center, India. Rekhi B, Dave V, Butle A, Dharavath B, Khetale S, Redhu AK, Singh R, Dutt A. Indian J Pathol Microbiol; 2024 Jul 01; 67(3):542-552. PubMed ID: 38391356 [Abstract] [Full Text] [Related]
15. Histone 3.3 mutations in giant cell tumor and giant cell-rich sarcomas of bone. Righi A, Mancini I, Gambarotti M, Picci P, Gamberi G, Marraccini C, Dei Tos AP, Simi L, Pinzani P, Franchi A. Hum Pathol; 2017 Oct 01; 68():128-135. PubMed ID: 28899740 [Abstract] [Full Text] [Related]
17. Diagnostic value of histone 3 mutations in osteoclast-rich bone tumors. Nohr E, Lee LH, Cates JM, Perizzolo M, Itani D. Hum Pathol; 2017 Oct 01; 68():119-127. PubMed ID: 28882701 [Abstract] [Full Text] [Related]